 | Up a level |
Therribout, Norman; van Kernebeek, Michiel W.; Vorspan, Florence; Crunelle, Cleo L.; van den Brink, Wim; Özgen, Heval; Spijkerman, Renske; Noack, Moritz; Holtmann, Martin; Schellekens, Arnt S.A.; van de Glind, Geurt; Hendriks, Vincent; Dom, Geert; Moggi, Franz; Konstenius, Maija; Franck, Johan; Levin, Frances R.; Ramos-Quiroga, J. Antoni; Demetrovics, Zsolt; Coetzee, Corné; ... (2023). International consensus statement for the screening, diagnosis, and treatment ofadolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder. Neuropsychiatrie de l'enfance et de l'adolescence, 71(1), pp. 25-34. Elsevier 10.1016/j.neurenf.2022.11.004
Brynte, Christoffer; Aeschlimann, Myriam; Barta, Csaba; Begeman, Alex Hendikus Abraham; Bäcker, Amanda; Crunelle, Cleo Lina; Daigre, Constanza; De Fuentes-Merillas, Laura; Demetrovics, Zsolt; Dom, Geert; López, Lara Grau; Icick, Romain; Johnson, Brian; Joostens, Peter; Kapitány-Fövény, Máté; Karsinti, Emily; Kiefer, Falk; Konstenius, Maija; Levin, Frances R; Luderer, Mathias; ... (2022). The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study. BMC psychiatry, 22(1), p. 625. BioMed Central 10.1186/s12888-022-04259-6
